Skip to main content

Advertisement

Log in

Prevalence of Helicobacter pylori infection and risk of upper gastrointestinal ulcer in patients with rheumatoid arthritis in Japan

  • ORIGINAL ARTICLE
  • Published:
Modern Rheumatology

Abstract

We evaluated the prevalence of Helicobacter pylori infection and the association of H. pylori infection and/or nonsteroidal anti-inflammatory drug (NSAID) use with upper gastrointestinal (UGI) ulcers in a cohort of Japanese patients with rheumatoid arthritis (RA). Using the clinical database of the cohort of RA patients and the serum titers of H. pylori antibody, 1815 patients were analyzed. Clinical data were successfully collected for 1529 patients over 2 years, and the history of NSAID use and the occurrence of newly diagnosed UGI ulcer were ascertained by patient self-reports and confirmed by their medical records. A total of 871 patients (49.3%) were H. pylori antibody-positive. Rates of positivity for H. pylori in patients with and without NSAID use were 47.5% and 54.7%, respectively (odds ratio = 0.75, 95% confidence intervals [CI]: 0.58–0.96). The incidence of newly diagnosed UGI ulcer was 0% in the H. pylori−/NSAID− group, 1.24% in the H. pylori−/NSAID+ group, 1.06% in the H. pylori+/NSAID− group, and 3.46% in the H. pylori+/NSAID+ group. The odds ratios of H. pylori infection and NSAID for the occurrence of new UGI ulcers after adjusting for age and sex were 2.97 (95% CI: 1.19–7.38) and 4.31 (95% CI: 0.57–32.4), respectively. Although the prevalence of H. pylori antibody was low in patients with RA compared with that in healthy Japanese individuals, H. pylori infection was a significant risk factor for UGI ulcer in patients with RA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. BJ Marshall (1994) ArticleTitle Helicobacter pylori Am J Gastroenterol 89 S116–28 Occurrence Handle8048402

    PubMed  Google Scholar 

  2. S Suerbaum P Michetti (2002) ArticleTitleHelicobacter pylori infection N Engl J Med 347 1175–86 Occurrence Handle10.1056/NEJMra020542 Occurrence Handle12374879

    Article  PubMed  Google Scholar 

  3. JJ Ofman CH MacLean WL Straus SC Morton ML Berger EA Roth et al. (2002) ArticleTitleA metaanalysis of severe upper gastrointestinal complications of nonsteroidal anti-inflammatory drugs J Rheumatol 29 804–12 Occurrence Handle11950025

    PubMed  Google Scholar 

  4. MM Wolfe DR Lichtenstein G Singh (1999) ArticleTitleGastrointestinal toxicity of nonsteroidal anti-inflammatory drugs N Engl J Med 340 1888–99 Occurrence Handle10.1056/NEJM199906173402407 Occurrence Handle10369853

    Article  PubMed  Google Scholar 

  5. SE Gabriel L Jaakkimainen C Bombardier (1991) ArticleTitleRisk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis Ann Intern Med 115 787–96 Occurrence Handle1834002

    PubMed  Google Scholar 

  6. M Asaka (Eds) (1999) Gastric cancer: Helicobacter pylori and gastroduodenal diseases (in Japanese) Sentan Igakusha Tokyo, Japan 116–26

    Google Scholar 

  7. M Asaka T Kimura M Kudo H Takeda S Mitani T Miyazaki et al. (1992) ArticleTitleRelationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population Gastroenterology 102 760–6 Occurrence Handle1537513

    PubMed  Google Scholar 

  8. Y Shiokawa M Nobunaga T Saito S Asaki N Ogawa (1991) ArticleTitleEpidemiology study on upper gastrointestinal lesions induced by non-steroidal anti-inflammatory drugs (in Japanese) Ryumachi 31 96–111 Occurrence Handle1858000

    PubMed  Google Scholar 

  9. JQ Huang S Sridhar RH Hunt (2002) ArticleTitleRole of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis Lancet 359 14–22 Occurrence Handle10.1016/S0140-6736(02)07273-2 Occurrence Handle11809181

    Article  PubMed  Google Scholar 

  10. Y Matsuda G Singh H Yamanaka E Tanaka W Urano A Taniguchi et al. (2003) ArticleTitleValidation of a Japanese version of the Stanford Health Assessment Questionnaire in 3763 patients with rheumatoid arthritis Arthritis Rheum 49 784–8 Occurrence Handle10.1002/art.11465 Occurrence Handle14673964

    Article  PubMed  Google Scholar 

  11. FC Arnett SM Edworthy DA Bloch DJ McShane JF Fries NS Cooper et al. (1988) ArticleTitleThe American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 315–24 Occurrence Handle3358796

    PubMed  Google Scholar 

  12. T Kawai K Kawakami T Kudo S Ogiahara Y Handa F Moriyasu (2002) ArticleTitleA new serum antibody test kit (E plate) for evaluation of Helicobacter pylori eradication Intern Med 41 780–3 Occurrence Handle12412995

    PubMed  Google Scholar 

  13. T Fujioka M Tokieda (2000) ArticleTitleValidity of serum anti-Helicobacter pylori antibody using enzyme immunoassay for the diagnosis in eradication of Helicobacter pylori (in Japanese) Jpn J Med Pharm Sci 43 573–9

    Google Scholar 

  14. H Miwa S Kikuchi K Ohtaka O Kobayashi A Ogihara M Hojo et al. (2000) ArticleTitleInsufficient diagnostic accuracy of imported serological kits for Helicobacter pylori infection in Japanese population Diagn Microbiol Infect Dis 36 95–9 Occurrence Handle10.1016/S0732-8893(99)00143-1 Occurrence Handle10705050

    Article  PubMed  Google Scholar 

  15. Y Ohtsuka T Shimada N Watanabe H Akiyama Y Suzuki M Ishida et al. (1997) ArticleTitleAnalysis of the vacA gene sequences among Helicobacter pylori strains isolated from Japanese patients (abstract) Gastroenterology 112 A243

    Google Scholar 

  16. DY Graham DJ Evans SuffixJr J Peacock JT Baker WH Schrier (1996) ArticleTitleComparison of rapid serological tests (FlexSure HP and QuickVue) with conventional ELISA for detection of Helicobacter pylori infection Am J Gastroenterol 91 942–8 Occurrence Handle8633585

    PubMed  Google Scholar 

  17. B Khanna A Cutler NR Israel M Perry A Lastovica PI Fields et al. (1998) ArticleTitleUse caution with serologic testing for Helicobacter pylori infection in children J Infect Dis 178 460–5 Occurrence Handle9697727

    PubMed  Google Scholar 

  18. AE van Ede RF Laan HJ Blom RA De Abreu LB van de Putte (1998) ArticleTitleMethotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity Semin Arthritis Rheum 27 277–92 Occurrence Handle10.1016/S0049-0172(98)80049-8 Occurrence Handle9572710

    Article  PubMed  Google Scholar 

  19. TR Cupps TL Gerrard RJ Falkoff G Whalen AS Fauci (1985) ArticleTitleEffects of in vitro corticosteroids on B cell activation, proliferation, and differentiation J Clin Invest 75 754–61 Occurrence Handle3871795

    PubMed  Google Scholar 

  20. M Caselli P Pazzi R LaCorte A Aleotti L Trevisani G Stabellini (1989) ArticleTitleCampylobacter-like organisms, nonsteroidal anti-inflammatory drugs and gastric lesions in patients with rheumatoid arthritis Digestion 44 101–4 Occurrence Handle2612748

    PubMed  Google Scholar 

  21. AS Taha I Nakshabendi FD Lee RD Sturrock RI Russell (1992) ArticleTitleChemical gastritis and Helicobacter pylori related gastritis in patients receiving non-steroidal anti-inflammatory drugs: comparison and correlation with peptic ulceration J Clin Pathol 45 135–9 Occurrence Handle1541693

    PubMed  Google Scholar 

  22. L Laine M Marin-Sorensen WM Weinstein (1992) ArticleTitleNonsteroidal anti-inflammatory drug-associated gastric ulcers do not require Helicobacter pylori for their development Am J Gastroenterol 87 1398–402 Occurrence Handle1415094

    PubMed  Google Scholar 

  23. N Hudson M Balsitis F Filipowicz CJ Hawkey (1993) ArticleTitleEffect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs Gut 34 748–51 Occurrence Handle8314505

    PubMed  Google Scholar 

  24. Y Mizokami K Tamura Y Fukuda I Yamamoto T Shimoyama (1994) ArticleTitleNon-steroidal anti-inflammatory drugs associated with gastroduodenal injury and Helicobacter pylori Eur J Gastroenterol Hepatol 6 IssueIDsuppl 1 S109–12 Occurrence Handle7735925

    PubMed  Google Scholar 

  25. G Singh D Rosen Ramey (1998) ArticleTitleNSAID induced gastrointestinal complications: the ARAMIS perspective—1997. Arthritis, rheumatism, and aging medical information system J Rheumatol 51 IssueIDsuppl 8–16 Occurrence Handle9596549

    PubMed  Google Scholar 

  26. CJ Hawkey (1999) ArticleTitleCOX-2 inhibitors Lancet 353 307–14 Occurrence Handle10.1016/S0140-6736(98)12154-2 Occurrence Handle9929039

    Article  PubMed  Google Scholar 

  27. LS Simon AL Weaver DY Graham AJ Kivitz PE Lipsky RC Hubbard et al. (1999) ArticleTitleAnti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial JAMA 282 1921–8 Occurrence Handle10.1001/jama.282.20.1921 Occurrence Handle10580457

    Article  PubMed  Google Scholar 

  28. F Wolfe J Anderson TA Burke LM Arguelles D Pettitt (2002) ArticleTitleGastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy J Rheumatol 29 467–73 Occurrence Handle11908558

    PubMed  Google Scholar 

  29. P Ekstrom L Carling S Wetterhus PE Wingren O Anker-Hansen G Lundegardh et al. (1996) ArticleTitlePrevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study Scand J Gastroenterol 31 753–8 Occurrence Handle8858742

    PubMed  Google Scholar 

  30. ND Yeomans Z Tulassay L Juhasz I Racz JM Howard CJ van Rensburg et al. (1998) ArticleTitleA comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal anti-inflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group N Engl J Med 338 719–26 Occurrence Handle10.1056/NEJM199803123381104 Occurrence Handle9494148

    Article  PubMed  Google Scholar 

  31. CJ Hawkey JA Karrasch L Szczepanski DG Walker A Barkun AJ Swannell et al. (1998) ArticleTitleOmeprazole compared with misoprostol for ulcers associated with nonsteroidal anti-inflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group N Engl J Med 338 727–34 Occurrence Handle10.1056/NEJM199803123381105 Occurrence Handle9494149

    Article  PubMed  Google Scholar 

  32. DY Graham NM Agrawal SH Roth (1988) ArticleTitlePrevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial Lancet 2 1277–80 Occurrence Handle10.1016/S0140-6736(88)92892-9 Occurrence Handle2904006

    Article  PubMed  Google Scholar 

  33. InstitutionalAuthorNameAmerican College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines (2002) ArticleTitleGuidelines for the management of rheumatoid arthritis: 2002 Update Arthritis Rheum 46 328–46

    Google Scholar 

  34. A Yanagawa T Endo (2001) ArticleTitleRetrospective 10 years large scale evaluation of gastrointestinal lesion associated with NSAIDs in 9084 patients with rheumatoid arthritis and osteoarthritis and prophylactic efficacy of teprenone against NSAIDs AGML (in Japanese) Inflamm Regener 21 149–53

    Google Scholar 

  35. G Singh G Triadafilopoulos (1999) ArticleTitleEpidemiology of NSAID induced gastrointestinal complications J Rheumatol 26 IssueIDsuppl 18–24

    Google Scholar 

  36. JF Fries (1991) ArticleTitleNSAID gastropathy: the second most deadly rheumatic disease? Epidemiology and risk appraisal J Rheumatol 28 IssueIDsuppl 6–10

    Google Scholar 

  37. FK Chan JJ Sung SC Chung KF To MY Yung VK Leung et al. (1997) ArticleTitleRandomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers Lancet 350 975–9 Occurrence Handle10.1016/S0140-6736(97)04523-6 Occurrence Handle9329511

    Article  PubMed  Google Scholar 

  38. CJ Hawkey Z Tulassay L Szczepanski CJ van Rensburg A Filipowicz-Sosnowska A Lanas et al. (1998) ArticleTitleRandomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention Lancet 352 1016–21 Occurrence Handle10.1016/S0140-6736(98)04206-8 Occurrence Handle9759744

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eiichi Tanaka.

About this article

Cite this article

Tanaka, E., Singh, G., Saito, A. et al. Prevalence of Helicobacter pylori infection and risk of upper gastrointestinal ulcer in patients with rheumatoid arthritis in Japan. Mod Rheumatol 15, 340–345 (2005). https://doi.org/10.1007/s10165-005-0419-5

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10165-005-0419-5

Key words

Navigation